p38-MAPK inhibitor Doramapimod, Purity ≥98%

Cat. No.: X23-10-ZQ883

p38-MAPK inhibitor Doramapimod, Purity ≥98%

Synonym: Doramapimod; 285983-48-4; BIRB-796; BIRB 796; BIRB 796 (Doramapimod); BIRB796; BIRB-796 BS; p38-MAPK inhibitor

  • MDL: MFCD09752957
  • CAS Number: 285983-48-4
  • Compound CID: 156422
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Doramapimod, soluble in DMSO and ethanol and insoluble in water, targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates. It targets p38α and p38α.
Molecular Weight
527.7
Molecular Formula
C31H37N5O3
Targets
p38α: 0.1 nM (Kd); p38α: 38 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 99 mg/mL (187.61 mM); Water: Insoluble; Ethanol: 99 mg/mL (187.61 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Doramapimod can be applied to research focused on the inhibition of p38 MAP kinase in inflammatory diseases.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.